Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; 20230101, Issue: Preprints
- Subject
- Language
- ISSN
- 22132600; 22132619